Literature DB >> 8445366

Molecular characterization of two isolates of human T cell leukaemia virus type II from Italian drug abusers and comparison of genome structure with other isolates.

D Zella1, A Cavicchini, M Salemi, C Casoli, F Lori, G Achilli, E Cattaneo, V Landini, U Bertazzoni.   

Abstract

The human T cell leukaemia virus type II (HTLV-II), whose pathogenicity is as yet unclear, was recently found to be associated with intravenous drug abuse in North America and Europe. HTLV-II was isolated from two Italian drug abusers belonging to the same cohort and coinfected with human immunodeficiency virus type 1. Two new isolates, HTLV-II Gu and Va, were established in a culture of BJAB cells, a continuous B cell line (Epstein-Barr virus-negative), and characterized by nucleotide sequence analysis of the long terminal repeat (LTR) and portions of the gag, env and X regions. These sequences were compared to those of the HTLV-II Mo isolate reported in the literature. No major variations were observed in important regulatory elements of LTR nor in the stem-bulge-loop configuration known to be essential for binding of rex protein. The results obtained from the sequence of the 1988 nucleotides examined indicated a 1.6% variability between the Gu and Va isolates and about 6% with respect to Mo. Notable differences were found in the structure of putative open reading frames of the X region when compared to those reported for the Mo isolate. Restriction analysis of proviral DNA of two isolates and comparison with the physical map of the Mo isolate confirmed the existence of genetic heterogeneity in the HTLV-II group and demonstrated that the new isolates Gu and Va belong to the HTLV-IIb subtype. The results of this study show that the new isolates have distinct features with respect to the Mo isolate though all important regulatory elements of the LTR appear to be well conserved.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8445366     DOI: 10.1099/0022-1317-74-3-437

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  The origin and evolution of human T-cell lymphotropic virus types I and II.

Authors:  Y Suzuki; T Gojobori
Journal:  Virus Genes       Date:  1998       Impact factor: 2.332

2.  HTLV-II does not adversely affect the natural history of HIV-1 infection in intravenous drug users.

Authors:  G Magnani; G Elia; C Casoli; C Calzetti; A Degli Antoni; F Fiaccadori
Journal:  Infection       Date:  1995 Jan-Feb       Impact factor: 3.553

3.  Identification and characterization of a new and distinct molecular subtype of human T-cell lymphotropic virus type 2.

Authors:  N Eiraku; P Novoa; M da Costa Ferreira; C Monken; R Ishak; O da Costa Ferreira; S W Zhu; R Lorenco; M Ishak; V Azvedo; J Guerreiro; M P de Oliveira; P Loureiro; N Hammerschlak; S Ijichi; W M Hall
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

4.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

5.  Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb.

Authors:  W M Switzer; S M Owen; D A Pieniazek; V R Nerurkar; E Duenas-Barajas; W Heneine; R B Lal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

6.  Development and validation of a multiplex real-time PCR assay for simultaneous genotyping and human T-lymphotropic virus type 1, 2, and 3 proviral load determination.

Authors:  Britta Moens; Giovanni López; Vanessa Adaui; Elsa González; Lien Kerremans; Daniel Clark; Kristien Verdonck; Eduardo Gotuzzo; Guido Vanham; Olivier Cassar; Antoine Gessain; Anne-Mieke Vandamme; Sonia Van Dooren
Journal:  J Clin Microbiol       Date:  2009-09-09       Impact factor: 5.948

7.  Evaluation of Sensitivity and Specificity Performance of Elecsys HTLV-I/II Assay in a Multicenter Study in Europe and Japan.

Authors:  Syria Laperche; Silvia Sauleda; Maria Piron; Annelies Mühlbacher; Harald Schennach; Volkmar Schottstedt; Lucinda Queirós; Naoki Uno; Katsunori Yanagihara; Roland Imdahl; Ariann Hey; Markus Klinkicht; Walter Melchior; Peter Muench; Toshiki Watanabe
Journal:  J Clin Microbiol       Date:  2017-05-03       Impact factor: 5.948

8.  Nucleotide sequence variation of human T-lymphotropic virus type II in Vietnam.

Authors:  H Yoshizaki; T Nakasone; T Nakasatomi; S Kusagawa; H Sato; T H Nguyen; H A Mai; T L Hoang; Y Takebe; M Honda
Journal:  Jpn J Cancer Res       Date:  1997-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.